Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | May 10, 2019 at 9:50 AM EDT

Short Sellers Get Even Higher on Cannabis Stocks

The April 30 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | May 10, 2019 at 8:55 AM EDT

Short Sellers Back Off Major Biotechs

The April 30 short interest data have been compared with the previous report, and short interest in most of these…

Jon C. Ogg | May 9, 2019 at 2:10 PM EDT

2 Pharma Giants Shine as Wall Street Brings Strong IPOs for Cortexyme and NextCure

It's an impressive day when two IPOs are well received when drug-selling revenues are unlikely for quite some time, and…

Chris Lange | May 7, 2019 at 11:30 AM EDT

Why Mylan Is Getting Absolutely Crushed

Mylan released mixed first-quarter financial results before the markets opened on Tuesday, and share plunged afterward.

Chris Lange | May 7, 2019 at 9:45 AM EDT

Osmotica Pharma Makes Significant Headway With Ptosis Treatment

Osmotica Pharma shares jumped on Tuesday after the firm announced results from its late-stage trial for the treatment of ptosis…

Chris Lange | May 6, 2019 at 11:05 AM EDT

What to Expect When Mylan Reports Tuesday

Mylan is scheduled to release its first-quarter financial results before the markets open on Tuesday, and earnings are expected to…

Chris Lange | May 6, 2019 at 8:59 AM EDT

What Cytokinetics New Study Means for ALS Patients

Cytokinetics shares took a step back on Monday after the firm announced that its midstage trial for ALS failed to…

Jon C. Ogg | May 2, 2019 at 4:53 PM EDT

Is Gilead’s Stock and Revenue Free-Fall Finally Bottoming Out?

It’s no simple task for a biotech giant to try to sell itself to investors as a value stock. That…

Chris Lange | May 1, 2019 at 9:55 AM EDT

Why the FDA Is Crushing Nabriva’s UTI Treatment

Nabriva Therapeutics shares dropped sharply on Wednesday after the firm received a warning from the FDA for the New Drug…

Chris Lange | May 1, 2019 at 7:35 AM EDT

Good News for Ovarian Cancer Treatment

Hermispherx Biopharma shares shot up on Tuesday after the firm announced significant progress in its Ampligen recurrent ovarian cancer program…

Jon C. Ogg | Apr 30, 2019 at 2:25 PM EDT

Potentially Good News for Those Who Suffer From Pompe Disease

There may be some good news developing for those who suffer from Pompe Disease. Amicus Therapeutics, Inc. (NASDAQ: FOLD) has…

Paul Ausick | Apr 30, 2019 at 12:15 PM EDT

Why Pfizer Shareholders Are Smiling After Earnings

Drugmaker Pfizer beat estimates on both the top and bottom lines for the first quarter, and shares rallied after the…

Douglas A. McIntyre | Apr 30, 2019 at 8:32 AM EDT

The One Almost Sure Sign You Have Measles

While measles has a number of telling symptoms, many are common with other infections. One, however, is a telltale sign…

Chris Lange | Apr 26, 2019 at 9:40 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The April 15 short interest data have been compared with the previous report, and short interest moves in these selected…

Chris Lange | Apr 26, 2019 at 8:45 AM EDT

Big Pharma Scares Off Short Sellers

The April 15 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 99 100 101 102 103 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Short Sellers Get Even Higher on Cannabis Stocks

Short Sellers Back Off Major Biotechs

2 Pharma Giants Shine as Wall Street Brings Strong IPOs for Cortexyme and NextCure

Why Mylan Is Getting Absolutely Crushed

Osmotica Pharma Makes Significant Headway With Ptosis Treatment

What to Expect When Mylan Reports Tuesday

What Cytokinetics New Study Means for ALS Patients

Is Gilead’s Stock and Revenue Free-Fall Finally Bottoming Out?

Why the FDA Is Crushing Nabriva’s UTI Treatment

Good News for Ovarian Cancer Treatment

Potentially Good News for Those Who Suffer From Pompe Disease

Why Pfizer Shareholders Are Smiling After Earnings

The One Almost Sure Sign You Have Measles

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Big Pharma Scares Off Short Sellers

Bitcoin Price Hits $80K: We Asked Grok If BTC Could Hold $80K in May

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

Bitcoin Price Hits $80K: We Asked Grok If BTC Could Hold $80K in May

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

Health and Healthcare Articles

All Health and Healthcare Articles

Short Sellers Get Even Higher on Cannabis Stocks

Short Sellers Back Off Major Biotechs

2 Pharma Giants Shine as Wall Street Brings Strong IPOs for Cortexyme and NextCure

Why Mylan Is Getting Absolutely Crushed

Osmotica Pharma Makes Significant Headway With Ptosis Treatment

What to Expect When Mylan Reports Tuesday

What Cytokinetics New Study Means for ALS Patients

Is Gilead’s Stock and Revenue Free-Fall Finally Bottoming Out?

Why the FDA Is Crushing Nabriva’s UTI Treatment

Good News for Ovarian Cancer Treatment

Potentially Good News for Those Who Suffer From Pompe Disease

Why Pfizer Shareholders Are Smiling After Earnings

The One Almost Sure Sign You Have Measles

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Big Pharma Scares Off Short Sellers

Bitcoin Price Hits $80K: We Asked Grok If BTC Could Hold $80K in May

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up